In Restructuring, SurModics Rolls Arrays into IVD Business Unit, Cuts Workforce by 13 Percent | GenomeWeb

By Justin Petrone

SurModics last week announced a restructuring in which it will lay off 13 percent of its employees and rearrange its organizational structure into three business units.

The Eden Prairie, Minn.-based firm, which specializes in drug delivery and surface-modification technologies, said the changes are designed to "more closely match operations and cost structure with the current customer environment" and to maintain "investment in long-term growth initiatives."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.